Boehringer Ingelheim attacks IBD collaboratively

By Bill Fallon

No Comment

Boehringer Ingelheim in Ridgefield recently announced new collaborations with four scientific partners to better research and develop therapeutic approaches for patients with inflammatory bowel disease, often called IBD.

This content is for Westfair Online members only. Please login to view this content. Become a member by Registering Here. If you would prefer to start with a 12 week free trial, Click Here.


About the author

Bill Fallon
Bill Fallon is editor of the Fairfield County Business Journal. He has worked at Westfair Communications for more than five years, previously editing an upstate New York daily and a national motorcycle magazine in Nevada. He attended Iona Prep in New Rochelle, N.Y., and the University of Virginia.

Related Articles